Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Albireo Pharma, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 109 | 1 | 96 | −12 |
| Shares | 19.3M | 564 | 18.6M | −660.0K (−3.4%) |
| Value | $372.0M | $11.0K | $401.7M | +$29.7M (+8.0%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Albireo Pharma, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Saturn V Capital Management LLC | 341,827 | $6.86M | 5.70% |
| Great Point Partners LLC | 267,283 | $5.78M | 1.19% |
| Jacobs Levy Equity Management, Inc | 30,165 | $651.9K | 0.00% |
| BIT Capital GmbH | 27,876 | $602.4K | 0.13% |
| PDT Partners, LLC | 23,587 | $509.7K | 0.08% |
| Schonfeld Strategic Advisors LLC | 18,393 | $397.5K | 0.00% |
| Cheyne Capital Management (UK) LLP | 13,364 | $288.8K | 0.51% |
| Jump Financial, LLC | 11,700 | $252.8K | 0.01% |
Sold out (20)
Institutions that held Albireo Pharma, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Jane Street Group, LLC | 61,652 | $1.19M |
| HRT Financial LP | 48,539 | $939.0K |
| Walleye Capital LLC | 38,178 | $739.0K |
| Susquehanna International Group, LLP | 36,525 | $707.0K |
| ExodusPoint Capital Management, LP | 35,874 | $695.0K |
| New York Life Investments Alternatives | 34,524 | $668.0K |
| Prudential Financial Inc | 25,700 | $498.0K |
| Ergoteles LLC | 19,943 | $386.0K |
| Squarepoint Ops LLC | 16,061 | $311.0K |
| Walleye Trading LLC | 10,406 | $201.0K |
| Principal Financial Group Inc | 10,059 | $194.0K |
| Y-Intercept (Hong Kong) Ltd | 10,010 | $193.8K |
| SG Americas Securities, LLC | 8,583 | $166.0K |
| Psagot Value Holdings Ltd. / (Israel) | 6,800 | $132.0K |
| Point72 Hong Kong Ltd | 3,304 | $64.0K |
| The PNC Financial Services Group, Inc. | 1,000 | $19.0K |
| Macquarie Group Ltd | 0 | $8.00K |
| Aquatic Capital Management LLC | 200 | $4.00K |
| Cutler Group LP | 100 | $1.00K |
| Ellevest, Inc. | 21 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Albireo Pharma, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Wipfli Financial Advisors LLC, | 564 | $11.0K |